Verona, Italy

Sergio Melotto

USPTO Granted Patents = 1 


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Sergio Melotto

Introduction

Sergio Melotto is a notable inventor based in Verona, Italy. He has made significant contributions to the field of chemistry, particularly in the development of pharmaceutical compounds. His work has implications for medical applications, showcasing his expertise and innovative spirit.

Latest Patents

Sergio Melotto holds a patent for chemical compounds, specifically piperazine derivatives. This invention relates to processes for their preparation, pharmaceutical compositions containing these compounds, and their medical use. The novel compounds developed by Melotto act as antagonists of tachykinins, including substance P and other neurokinins, highlighting their potential therapeutic benefits.

Career Highlights

Throughout his career, Melotto has worked with prominent companies in the pharmaceutical industry. He has been associated with SmithKline Beecham Corporation and Glaxo Group Limited, where he contributed to various research and development projects. His experience in these organizations has enriched his knowledge and skills in the field of pharmaceuticals.

Collaborations

Sergio Melotto has collaborated with esteemed colleagues, including Giuseppe Alvaro and Romano Di Fabio. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Sergio Melotto's contributions to the field of chemistry and pharmaceuticals are noteworthy. His patent for piperazine derivatives demonstrates his innovative approach to medical applications. Through his work and collaborations, Melotto continues to impact the pharmaceutical industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…